• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定和验证一个与免疫相关的基因特征,可预测结肠癌的总生存期。

Identification and validation of an immune-related gene signature predictive of overall survival in colon cancer.

机构信息

Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou 450001, Henan, China.

Zhengzhou University Library, Zhengzhou University, Zhengzhou 450001, Henan, China.

出版信息

Aging (Albany NY). 2020 Dec 19;12(24):26095-26120. doi: 10.18632/aging.202317.

DOI:10.18632/aging.202317
PMID:33401247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7803520/
Abstract

The heterogeneity and complexity of tumor-immune microenvironments lead to diverse immunotherapy effects among colon cancer patients. It is crucial to identify immune microenvironment-related biomarkers and construct prognostic risk models. In this study, the immune and stromal scores of 415 cases from TCGA were calculated using the ESTIMATE algorithm. AXIN2, CCL22, CLEC10A, CRIP2, RUNX3, and TRPM5 were screened and established a prognostic immune-related gene (IRG) signature using by univariate, LASSO, and multivariate Cox regression models. The predicted performance of IRG signature was external validated by GSE39582 (n=519). Stratified survival analysis showed IRG signature was an effective predictor of survival in patients with different clinical characteristics. The protein expression level of six genes was validated by immunohistochemistry analysis. Difference analysis indicated the mutation rate, immune cell of resting NK cells and regulatory T cells infiltration and four immune checkpoints of PD-1, PD-L1, LAG3 and VSIR expression levels in the high-risk group were significantly higher than those in the low-risk group. A nomogram incorporating the gene signatures and clinical factors was demonstrated had a good accuracy (1-, 3-, and 5-year AUC= 0.799, 0.791, 0.738). Our study identified a novel IRG signature, which may provide some references for the clinical precision immunotherapy of patients.

摘要

肿瘤免疫微环境的异质性和复杂性导致结肠癌患者的免疫治疗效果各异。确定免疫微环境相关的生物标志物并构建预后风险模型至关重要。在这项研究中,使用 ESTIMATE 算法计算了来自 TCGA 的 415 例患者的免疫和基质评分。通过单变量、LASSO 和多变量 Cox 回归模型筛选并建立了 AXIN2、CCL22、CLEC10A、CRIP2、RUNX3 和 TRPM5 预后免疫相关基因 (IRG) 特征。IRG 特征的预测性能通过 GSE39582(n=519)进行了外部验证。分层生存分析表明,IRG 特征是不同临床特征患者生存的有效预测因子。通过免疫组织化学分析验证了六个基因的蛋白表达水平。差异分析表明,高危组的突变率、静止 NK 细胞和调节性 T 细胞浸润的免疫细胞以及四个免疫检查点 PD-1、PD-L1、LAG3 和 VSIR 的表达水平明显高于低危组。纳入基因特征和临床因素的列线图显示具有良好的准确性(1、3 和 5 年 AUC=0.799、0.791 和 0.738)。我们的研究确定了一个新的 IRG 特征,它可能为患者的临床精准免疫治疗提供一些参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/511d/7803520/2f5f5bb56f6b/aging-12-202317-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/511d/7803520/bf336e2c9d99/aging-12-202317-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/511d/7803520/ff2e58710035/aging-12-202317-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/511d/7803520/7a472f0b7d06/aging-12-202317-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/511d/7803520/7456e5295604/aging-12-202317-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/511d/7803520/2796bdb732cd/aging-12-202317-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/511d/7803520/db8a274bd5dd/aging-12-202317-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/511d/7803520/2668cbfb13bd/aging-12-202317-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/511d/7803520/a287b7284cf9/aging-12-202317-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/511d/7803520/2f5f5bb56f6b/aging-12-202317-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/511d/7803520/bf336e2c9d99/aging-12-202317-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/511d/7803520/ff2e58710035/aging-12-202317-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/511d/7803520/7a472f0b7d06/aging-12-202317-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/511d/7803520/7456e5295604/aging-12-202317-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/511d/7803520/2796bdb732cd/aging-12-202317-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/511d/7803520/db8a274bd5dd/aging-12-202317-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/511d/7803520/2668cbfb13bd/aging-12-202317-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/511d/7803520/a287b7284cf9/aging-12-202317-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/511d/7803520/2f5f5bb56f6b/aging-12-202317-g009.jpg

相似文献

1
Identification and validation of an immune-related gene signature predictive of overall survival in colon cancer.鉴定和验证一个与免疫相关的基因特征,可预测结肠癌的总生存期。
Aging (Albany NY). 2020 Dec 19;12(24):26095-26120. doi: 10.18632/aging.202317.
2
Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma.鉴定肿瘤免疫微环境相关的可变剪接事件,用于预测胰腺腺癌的预后。
BMC Cancer. 2021 Nov 12;21(1):1211. doi: 10.1186/s12885-021-08962-7.
3
Identification of a novel immune microenvironment signature predicting survival and therapeutic options for bladder cancer.鉴定一种新型免疫微环境特征,预测膀胱癌患者的生存和治疗选择。
Aging (Albany NY). 2020 Dec 19;13(2):2780-2802. doi: 10.18632/aging.202327.
4
Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma.基于炎症相关基因的结肠腺癌分子亚型鉴定和预后标志物。
Front Immunol. 2021 Dec 23;12:769685. doi: 10.3389/fimmu.2021.769685. eCollection 2021.
5
Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma.探讨结直肠腺癌中肿瘤突变负荷与免疫浸润的关系。
Int J Med Sci. 2021 Jan 1;18(3):685-694. doi: 10.7150/ijms.51918. eCollection 2021.
6
Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.建立一个与 IFNγ 反应相关的特征,用于预测皮肤黑色素瘤的生存情况。
Cancer Med. 2020 Nov;9(21):8186-8201. doi: 10.1002/cam4.3438. Epub 2020 Sep 9.
7
Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of colorectal cancer.结直肠癌肿瘤微环境中预后免疫相关基因的综合分析。
Aging (Albany NY). 2021 Feb 1;13(4):5506-5524. doi: 10.18632/aging.202479.
8
Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.鉴定和验证与肿瘤微环境相关的基因签名,用于晚期非小细胞肺癌的预后预测。
Biomed Res Int. 2021 Mar 30;2021:8864436. doi: 10.1155/2021/8864436. eCollection 2021.
9
A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.一种基于免疫相关基因的子宫颈鳞状细胞癌和子宫颈管腺癌预后标志物。
Int Immunopharmacol. 2020 Nov;88:106884. doi: 10.1016/j.intimp.2020.106884. Epub 2020 Aug 11.
10
Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer.鉴定预测结肠癌预后风险和淋巴细胞浸润的免疫特征。
Front Immunol. 2020 Sep 3;11:1678. doi: 10.3389/fimmu.2020.01678. eCollection 2020.

引用本文的文献

1
Cysteine-rich intestinal protein family: structural overview, functional diversity, and roles in human disease.富含半胱氨酸的肠道蛋白家族:结构概述、功能多样性及其在人类疾病中的作用。
Cell Death Discov. 2025 Mar 21;11(1):114. doi: 10.1038/s41420-025-02395-y.
2
Constructing and validating a novel prognostic risk score model for rectal cancer based on four immune-related genes.基于四个免疫相关基因构建并验证一种新型直肠癌预后风险评分模型。
Transl Cancer Res. 2025 Feb 28;14(2):1053-1069. doi: 10.21037/tcr-24-1511. Epub 2025 Feb 26.
3
Action of m6A-related gene signatures on the prognosis and immune microenvironment of colonic adenocarcinoma.

本文引用的文献

1
Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine.阻断 CTLA-4 可提高树突状细胞疫苗的抗肿瘤反应诱导潜能。
J Control Release. 2020 Oct 10;326:63-74. doi: 10.1016/j.jconrel.2020.06.017. Epub 2020 Jun 21.
2
The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types.7 种癌症类型 2033 转录组的肿瘤免疫微环境分析。
Sci Rep. 2020 Jun 12;10(1):9536. doi: 10.1038/s41598-020-66449-0.
3
Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer.
m6A相关基因特征对结肠腺癌预后及免疫微环境的作用
Heliyon. 2024 May 24;10(11):e31441. doi: 10.1016/j.heliyon.2024.e31441. eCollection 2024 Jun 15.
4
Identification of novel T cell proliferation patterns, potential biomarkers and therapeutic drugs in colorectal cancer.结直肠癌中新型T细胞增殖模式、潜在生物标志物及治疗药物的鉴定
J Cancer. 2024 Jan 1;15(5):1234-1254. doi: 10.7150/jca.91835. eCollection 2024.
5
Downstream STING pathways IRF3 and NF-κB differentially regulate CCL22 in response to cytosolic dsDNA.下游的 STING 通路 IRF3 和 NF-κB 对细胞质 dsDNA 作出反应时,以不同的方式调节 CCL22。
Cancer Gene Ther. 2024 Jan;31(1):28-42. doi: 10.1038/s41417-023-00678-z. Epub 2023 Nov 21.
6
ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, mA modification, and drug susceptibility.ZNF765 是与细胞周期、免疫浸润、mA 修饰和药物敏感性相关的肝细胞癌的预后生物标志物。
Aging (Albany NY). 2023 Jul 4;15(13):6179-6211. doi: 10.18632/aging.204827.
7
An N6-methyladenosine regulation- and mRNAsi-related prognostic index reveals the distinct immune microenvironment and immunotherapy responses in lower-grade glioma.N6-甲基腺苷调控和 mRNAsi 相关预后指数揭示了低级别脑胶质瘤中独特的免疫微环境和免疫治疗反应。
BMC Bioinformatics. 2023 Jun 1;24(1):225. doi: 10.1186/s12859-023-05328-7.
8
Cancer-Associated Fibroblast Risk Model for Prediction of Colorectal Carcinoma Prognosis and Therapeutic Responses.癌症相关成纤维细胞风险模型预测结直肠癌预后和治疗反应。
Mediators Inflamm. 2023 Apr 25;2023:3781091. doi: 10.1155/2023/3781091. eCollection 2023.
9
Peptide-based PET imaging agent of tumor TIGIT expression.基于肽的肿瘤TIGIT表达PET显像剂。
EJNMMI Res. 2023 May 2;13(1):38. doi: 10.1186/s13550-023-00982-7.
10
LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors.供者 LAG3 基因型与 HLA 完全匹配同胞供者异基因移植后的临床结局
Front Immunol. 2023 Jan 20;14:1066393. doi: 10.3389/fimmu.2023.1066393. eCollection 2023.
单细胞分析揭示与癌症免疫治疗耐药相关的成纤维细胞簇。
Cancer Discov. 2020 Sep;10(9):1330-1351. doi: 10.1158/2159-8290.CD-19-1384. Epub 2020 May 20.
4
Revolutionizing the landscape of colorectal cancer treatment: The potential role of immune checkpoint inhibitors.革新结直肠癌治疗格局:免疫检查点抑制剂的潜在作用。
Int J Cancer. 2020 Dec 1;147(11):2996-3006. doi: 10.1002/ijc.33056. Epub 2020 Jun 1.
5
Primary tumor location and survival in colorectal cancer: A retrospective cohort study.结直肠癌的原发肿瘤位置与生存情况:一项回顾性队列研究。
World J Gastrointest Oncol. 2020 Apr 15;12(4):405-423. doi: 10.4251/wjgo.v12.i4.405.
6
Identification of Hub Genes Related to Carcinogenesis and Prognosis in Colorectal Cancer Based on Integrated Bioinformatics.基于综合生物信息学的结直肠癌发生发展及预后相关的枢纽基因鉴定。
Mediators Inflamm. 2020 Apr 9;2020:5934821. doi: 10.1155/2020/5934821. eCollection 2020.
7
Tripterine Restrains the Aggressiveness of Hepatocellular Carcinoma Cell via Regulating miRNA-532-5p/CXCL2 Axis.雷公藤红素通过调控miRNA-532-5p/CXCL2轴抑制肝癌细胞的侵袭性。
Onco Targets Ther. 2020 Apr 8;13:2973-2985. doi: 10.2147/OTT.S238074. eCollection 2020.
8
Prognostic values of immune scores and immune microenvironment-related genes for hepatocellular carcinoma.免疫评分和免疫微环境相关基因对肝细胞癌的预后价值。
Aging (Albany NY). 2020 Mar 25;12(6):5479-5499. doi: 10.18632/aging.102971.
9
Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer.结直肠癌免疫图谱、遗传亚型与免疫治疗应答的关系。
Front Immunol. 2020 Mar 6;11:369. doi: 10.3389/fimmu.2020.00369. eCollection 2020.
10
Identification of prognostic immune-related genes in the tumor microenvironment of endometrial cancer.识别子宫内膜癌肿瘤微环境中的预后免疫相关基因。
Aging (Albany NY). 2020 Feb 19;12(4):3371-3387. doi: 10.18632/aging.102817.